Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 21, 1986 - Issue 4
Submit an article Journal homepage
7
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Effects of Omeprazole in Duodenal Ulcer Patients

A. L. Karvonen Tampere Central University Hospital, Tampere, and Helsinki University Hospital, Helsinki, Finland, and Research Laboratories, AB Hassle, Molndal, Sweden
,
O. Keyriläinen Tampere Central University Hospital, Tampere, and Helsinki University Hospital, Helsinki, Finland, and Research Laboratories, AB Hassle, Molndal, Sweden
,
A. Uusitalo Tampere Central University Hospital, Tampere, and Helsinki University Hospital, Helsinki, Finland, and Research Laboratories, AB Hassle, Molndal, Sweden
,
M. Salaspuro Tampere Central University Hospital, Tampere, and Helsinki University Hospital, Helsinki, Finland, and Research Laboratories, AB Hassle, Molndal, Sweden
,
S. Tarpila Tampere Central University Hospital, Tampere, and Helsinki University Hospital, Helsinki, Finland, and Research Laboratories, AB Hassle, Molndal, Sweden
,
K. Andrén Tampere Central University Hospital, Tampere, and Helsinki University Hospital, Helsinki, Finland, and Research Laboratories, AB Hassle, Molndal, Sweden
&
H. F. Helander Tampere Central University Hospital, Tampere, and Helsinki University Hospital, Helsinki, Finland, and Research Laboratories, AB Hassle, Molndal, Sweden
 show all
Pages 449-454 | Received 26 Aug 1985, Accepted 30 Oct 1985, Published online: 08 Jul 2009

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

G. Bianchi Porro & F. Parente. (1989) Omeprazole in the Treatment of Duodenal Ulcer. Scandinavian Journal of Gastroenterology 24:sup166, pages 48-53.
Read now
H. G. Dammann, M. Dreyer, R. Kangah, P. Müller & B. Simon. (1988) First-Choice Treatment in Uncomplicated Ulcer Disease: A Case for Acid Inhibitors. Scandinavian Journal of Gastroenterology 23:sup153, pages 62-70.
Read now

Articles from other publishers (18)

Francesco Di Mario, Giuseppe Battaglia, Michele De Boni, Emanuela De Bona, Gioacchino Leandro, Giorgio Chiozzini, Michele Pasini, Giovanni Andrea Grasso, Marina Ferrana, Alfredo Saggioro & Marcello Pasquino. (1996) Omeprazole in the maintenance treatment of duodenal ulcer: results after 6 months of 20 mg daily, 20 mg every other day, or 40 mg on weekends. Current Therapeutic Research 57:1, pages 33-41.
Crossref
R. F. McCloy, R. Arnold, K. D. Bardhan, D. Cattan, E. Klinkenberg-Knol, P. N. Maton, R. H. Riddell, P. Sipponen & A. Walan. (1995) Pathophysiological effects of long-term acid suppression in man. Digestive Diseases and Sciences 40:S2, pages 96S-120S.
Crossref
M.J. Arens & J. Dent. (1993) Acid pump blockers: what are their current therapeutic roles?. Baillière's Clinical Gastroenterology 7:1, pages 95-128.
Crossref
Firouzan Massoomi, John Savage & Christopher J. Destache. (2012) Omeprazole: A Comprehensive Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 13:1, pages 46-59.
Crossref
David V. Feliciano. (1992) Do perforated duodenal ulcers need an aciddecreasing surgical procedure now that omeprazole is available?. Surgical Clinics of North America 72:2, pages 369-380.
Crossref
John A. Oates, Alastair J.J. Wood & Paul N. Maton. (1991) Omeprazole. New England Journal of Medicine 324:14, pages 965-975.
Crossref
R. G. Berlin. (1991) Omeprazole. Digestive Diseases and Sciences 36:2, pages 129-136.
Crossref
Karsten Lauritsen, Bent Nyboe Andersen, Laurits Stærk Laursen, Jeppe Hansen, Troels Havelund, Jan Eriksen, Jens F. Rehfeld, Johan Kjærgaard & Jörgen Rask-madsen. (1991) Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Gastroenterology 100:3, pages 663-669.
Crossref
P. N. Maton, G. Sachs & B. Wallmark. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease 159 187 .
Herbert F. Helander, Magnus Simonsson, Frank Sundler, Kerstin Rutgersson, Kerstin G. Helander & Sven Eriksson. (1990) Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists. Virchows Archiv A Pathological Anatomy and Histopathology 417:4, pages 305-309.
Crossref
H. Lönroth, E. Rosengren, L. Olbe & L. Lundell. (1990) Histamine metabolism in human gastric mucosa. Gastroenterology 98:4, pages 921-928.
Crossref
David Y. Graham, Arthur McCullough, Manuel Sklar, Stephen J. Sontag, Walter M. Roufail, Richard C. Stone, Robert H. Bishop, Norman Gitlin, Angeline J. Cagliola, Rayanne S. Berman & Thomas J. Humphries. (1990) Omeprazole versus placebo in duodenal ulcer healing. Digestive Diseases and Sciences 35:1, pages 66-72.
Crossref
Per Lindberg, Arne Brändström, Björn Wallmark, Hillevi Mattsson, Leif Rikner & Kurt‐Jürgen Hoffmann. (2006) Omeprazole: The first proton pump inhibitor. Medicinal Research Reviews 10:1, pages 1-54.
Crossref
E G Hewson, N D Yeomans, P W Angus, A Shulkes, C W Brook, R B Sewell & R A Smallwood. (1988) Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients.. Gut 29:12, pages 1715-1720.
Crossref
J. M. POLAK & S. R. BLOOM. (2007) Review: the enterochromaffin‐like cell, intragastric acidity and the trophic effect of plasma gastrin. Alimentary Pharmacology & Therapeutics 2:4, pages 291-296.
Crossref
K Lauritsen, S J Rune, H R Wulff, J H Olsen, L S Laursen, T Havelund, L Astrup, F Bendtsen, J Linde & P Bytzer. (1988) Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.. Gut 29:2, pages 249-253.
Crossref
T Havelund, L S Laursen, E Skoubo-Kristensen, B N Andersen, S A Pedersen, K B Jensen, C Fenger, F Hanberg-Sorensen & K Lauritsen. (1988) Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. BMJ 296:6615, pages 89-92.
Crossref
H. G. DAMMANN, TH. A. WALTER, M. DREYER, B. DAU, P. MÜLLER & B. SIMON. (2007) What are the current possibilities in treating peptic ulcer disease?. Alimentary Pharmacology & Therapeutics 1, pages 468s-492s.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.